Cycloserine rTMS Plasticity Augmentation in Depression

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 3, 2018

Primary Completion Date

December 8, 2020

Study Completion Date

April 21, 2021

Conditions

Major Depressive Disorder

Interventions

DRUG

Cycloserine

Cycloserine 100mg

DEVICE

Transcranial Magnetic Stimulation

Single-pulse transcranial magnetic stimulation and theta-burst stimulation

DRUG

Placebo Oral Tablet

Placebo tablet matched to cycloserine tab

Trial Locations (1)

University of Calgary, Calgary

All Listed Sponsors

lead

University of Calgary

OTHER

NCT03511599 - Cycloserine rTMS Plasticity Augmentation in Depression | Biotech Hunter | Biotech Hunter